Haft Jay M
Director at KINS
- Sold, on record
- $948k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 14, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KINSKINGSTONE COMPANIES, INC.Director
Sales by reason
0
Routine
1
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Feb 14, 2017Unusual
Sold 33.3% of their holdings
$511k45,218 shares at $11.31
- Jan 31, 2017Plan not stated
Sold 22.2% of their holdings
$437k38,634 shares at $11.31
2 of 2
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2020 | Jan 7, 2020 | KINS | Director | Awarded | 5,038 | 103,714 | SEC | ||
| Jun 25, 2019 | Jun 27, 2019 | KINS | Director | Bought | 2,000 | $8.50 | $17k | 98,676 | SEC |
| May 20, 2019 | May 22, 2019 | KINS | Director | Bought | 2,000 | $9.00 | $18k | 96,676 | SEC |
| Jan 2, 2019 | Jan 4, 2019 | KINS | Director | Awarded | 2,253 | 94,676 | SEC | ||
| Jan 16, 2018 | Jan 17, 2018 | KINS | Director | Awarded | 2,000 | 92,423 | SEC | ||
| Feb 14, 2017 | Feb 15, 2017 | KINS | Director | Sold | 45,218 | $11.31 | $511k | 90,423 | SEC |
| Jan 31, 2017 | Feb 1, 2017 | KINS | Director | Sold | 38,634 | $11.31 | $437k | 135,641 | SEC |
| Jan 4, 2017 | Jan 6, 2017 | KINS | Director | Awarded | 2,000 | 174,275 | SEC | ||
| Jan 4, 2016 | Jan 5, 2016 | KINS | Director | Awarded | 2,000 | 172,275 | SEC | ||
| Nov 30, 2015 | Dec 15, 2015 | Neurotrope, Inc. | Director | ConvertedSeries A Convertible Preferred Stock | 74,000 | 0 | SEC | ||
| Nov 30, 2015 | Dec 15, 2015 | Neurotrope, Inc. | Director | Converted | 88,252 | $0.84 | $74k | 88,252 | SEC |
| Nov 19, 2015 | Nov 20, 2015 | Neurotrope, Inc. | Director | AwardedOptions (right to buy) | 50,000 | 50,000 | SEC | ||
| Nov 13, 2015 | Nov 17, 2015 | Neurotrope, Inc. | Director | BoughtSeries B Preferred Stock | 208,752 | 41,667 | SEC | ||
| Dec 20, 2012 | Dec 20, 2012 | DUSA PHARMACEUTICALS INC | Director | Tendered | 98,500 | $8.00 | $788k | 0 | SEC |
| Dec 20, 2012 | Dec 20, 2012 | DUSA PHARMACEUTICALS INC | Director | Returned to the companyNon-qualified Stock Options | 70,000 | 0 | SEC | ||
| Jun 30, 2012 | Jul 2, 2012 | DUSA PHARMACEUTICALS INC | Director | Awarded | 8,000 | 64,000 | SEC | ||
| Mar 13, 2012 | Mar 14, 2012 | DUSA PHARMACEUTICALS INC | Director | Exercised or settledNon-Qualified Stock Option | 20,000 | 0 | SEC | ||
| Mar 13, 2012 | Mar 14, 2012 | DUSA PHARMACEUTICALS INC | Director | Exercised options | 20,000 | $2.71 | $54k | 56,000 | SEC |
| Aug 9, 2011 | Aug 10, 2011 | DUSA PHARMACEUTICALS INC | Director | Bought | 3,000 | $4.05 | $12k | 36,000 | SEC |
| Jun 30, 2011 | Jul 1, 2011 | DUSA PHARMACEUTICALS INC | Director | Awarded | 8,000 | 33,000 | SEC | ||
| Sep 30, 2010 | Oct 1, 2010 | KINS | Director | Awarded | 1,147 | 168,621 | SEC | ||
| Jun 30, 2010 | Jul 1, 2010 | DUSA PHARMACEUTICALS INC | Director | AwardedNon-Qualified Stock Option | 10,000 | 10,000 | SEC | ||
| Jun 30, 2010 | Jul 13, 2010 | KINS | Director | Awarded | 962 | 167,474 | SEC | ||
| May 6, 2010 | May 11, 2010 | KINS | Director | Awarded | 756 | 166,512 | SEC | ||
| Mar 5, 2010 | Mar 8, 2010 | DUSA PHARMACEUTICALS INC | Director | Bought | 10,000 | $1.72 | $17k | 25,000 | SEC |
| Dec 31, 2009 | Jan 5, 2010 | KINS | Director | Awarded | 1,674 | 165,756 | SEC | ||
| Jul 28, 2009 | Aug 25, 2009 | KINS | Director | Awarded | 1,361 | 164,082 | SEC | ||
| Jun 30, 2009 | Jul 1, 2009 | DUSA PHARMACEUTICALS INC | Director | AwardedNon-Qualified Stock Option | 10,000 | 10,000 | SEC | ||
| Mar 13, 2009 | Mar 17, 2009 | DUSA PHARMACEUTICALS INC | Director | Awarded | 15,000 | 15,000 | SEC | ||
| Sep 30, 2008 | Oct 2, 2008 | KINS | Director | Awarded | 3,125 | 162,721 | SEC | ||
| Jun 30, 2008 | Jul 1, 2008 | DUSA PHARMACEUTICALS INC | Director | AwardedNon-Qualified Stock Option | 10,000 | 10,000 | SEC | ||
| Jun 30, 2008 | Jul 9, 2008 | KINS | Director | Awarded | 2,475 | 159,596 | SEC | ||
| Mar 31, 2008 | Apr 23, 2008 | KINS | Director | Awarded | 1,497 | 157,121 | SEC | ||
| Jul 19, 2007 | Jul 23, 2007 | MOSCOW CABLECOM CORP | Director | OtherWarrants to purchase common stock | 6,044 | $3.05 | $18k | 0 | SEC |
| Jul 19, 2007 | Jul 23, 2007 | MOSCOW CABLECOM CORP | Director | Other | 33,338 | $12.90 | $430k | 0 | SEC |
| Jun 30, 2007 | Jul 2, 2007 | DUSA PHARMACEUTICALS INC | Director | AwardedNon-Qualified Stock Option | 10,000 | 10,000 | SEC | ||
| Mar 30, 2007 | Apr 3, 2007 | MOSCOW CABLECOM CORP | Director | Awarded | 1,250 | 33,338 | SEC | ||
| Jan 3, 2007 | Jan 4, 2007 | MOSCOW CABLECOM CORP | Director | Awarded | 6,250 | 32,088 | SEC | ||
| Sep 29, 2006 | Oct 2, 2006 | MOSCOW CABLECOM CORP | Director | Awarded | 1,250 | 25,838 | SEC | ||
| Jul 6, 2006 | Jul 7, 2006 | MOSCOW CABLECOM CORP | Director | Awarded | 1,250 | 24,588 | SEC | ||
| Jun 30, 2006 | Jul 5, 2006 | DUSA PHARMACEUTICALS INC | Director | AwardedNon-Qualified Stock Option | 10,000 | 10,000 | SEC | ||
| May 18, 2006 | May 22, 2006 | MOSCOW CABLECOM CORP | Director | BoughtWarrant | 6,044 | $0.0600 | $363 | 6,044 | SEC |
| May 18, 2006 | May 22, 2006 | MOSCOW CABLECOM CORP | Director | Bought | 12,088 | $8.21 | $99k | 23,338 | SEC |
| Mar 31, 2006 | Apr 3, 2006 | MOSCOW CABLECOM CORP | Director | Awarded | 1,250 | 11,250 | SEC | ||
| Jan 3, 2006 | Jan 3, 2006 | MOSCOW CABLECOM CORP | Director | Awarded | 5,000 | 10,000 | SEC |